Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review.
Clin Pharmacokinet
; 61(10): 1331-1343, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-36040613
Full text:
1
Database:
MEDLINE
Main subject:
Pancreatitis
/
COVID-19 Drug Treatment
Limits:
Humans
Language:
En
Journal:
Clin Pharmacokinet
Year:
2022
Type:
Article
Affiliation country:
Australia